Clinical Trial Update: Telemedicine Program in Type 1 Diabetes and CSII [NA]

View source ↗

Summary

An update on a completed clinical trial evaluating a telemedicine program for Type 1 diabetes managed with continuous subcutaneous insulin infusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Conditions: Diabetes Mellitus, Type 1 | NA | Status: COMPLETED